ECOR
NASDAQ HealthcareelectroCore, Inc. - Common Stock
Medical Devices
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
๐ Market Data
| Price | $10.25 |
|---|---|
| Volume | 144,152 |
| Market Cap | 92.41M |
| Beta | 0.940 |
| RSI (14-Day) | 95.2 Overbought |
| 200-Day MA | $6.53 |
| 50-Day MA | $7.73 |
| 52-Week High | $10.68 |
| 52-Week Low | $4.41 |
| Forward P/E | -18.64 |
| Price / Book | -33.06 |
๐ฏ Investment Strategy Scores
ECOR scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (99/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ Institutional Whale (1/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find ECOR in your text
Paste any article, transcript, or post โ the tool will extract ECOR and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.